Načítá se...
An osteoclastogenesis system, the RANKL/RANK signalling pathway, contributes to aggravated allergic inflammation
BACKGROUND AND PURPOSE: As an osteoclast differentiation factor, receptor activator of NF‐κB ligand (RANKL) is produced by various immune cells and may be involved in the pathogenesis of osteoporosis and inflammation. Although RANKL is expressed in most immune cells and tissues, it is not clear how...
Uloženo v:
| Vydáno v: | Br J Pharmacol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6514295/ https://ncbi.nlm.nih.gov/pubmed/30737962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14615 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|